Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo
about
Advancing Clostridia to Clinical Trial: Past Lessons and Recent ProgressSBRC-Nottingham: sustainable routes to platform chemicals from C1 waste gasesGenome sequence of Clostridium sporogenes DSM 795(T), an amino acid-degrading, nontoxic surrogate of neurotoxin-producing Clostridium botulinum.A universal mariner transposon system for forward genetic studies in the genus ClostridiumPotent and tumor specific: arming bacteria with therapeutic proteins.Clostridium to treat cancer: dream or reality?Complete Genome Sequence of the Nonpathogenic Soil-Dwelling Bacterium Clostridium sporogenes Strain NCIMB 10696.Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects.A roadmap for gene system development in Clostridium.Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.Evaluation of NfsA-like nitroreductases from Neisseria meningitidis and Bartonella henselae for enzyme-prodrug therapy, targeted cellular ablation, and dinitrotoluene bioremediation.Clostridium difficile Genome Editing Using pyrE Alleles.Protein Secretion in Gram-Positive Bacteria: From Multiple Pathways to Biotechnology.Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: Set the bugs to work?Attenuated Bacteria as Immunotherapeutic Tools for Cancer Treatment.
P2860
Q26745551-BFAE7879-0399-4AD9-AF49-FB462F315DEAQ26747222-453A30E9-AF32-4812-9D97-076ED5306291Q30659248-04D32B6E-F6A7-43AB-8F2F-A937C8B7D446Q35249672-470EDE6D-FD28-4229-A1EF-4BBC68C28B64Q35579375-466BE977-EC5D-480D-9DA2-CA18B6F52A54Q35625219-879E23B6-24E7-4488-89B9-A9545F5A6D26Q35751927-DA9285F0-41FA-4658-ABEA-03A6BBD66835Q38806283-38E3149C-F285-4525-967E-78078580F288Q38846364-CF2E6F4E-52B2-493D-BEC7-9D5ACF81ED37Q46247736-9CE4B5FE-D1D9-44B1-8430-29A2ADC07906Q47393198-2016722E-8796-42DF-AFF5-D3E7039FA889Q48045806-CE1E5D53-18C5-424A-AE6D-A16643E31353Q51093436-48C7C0DA-69FF-4063-845B-482F01C80F22Q52676917-2B75A2E5-9658-4DBF-956A-BCECC2F8B3A7Q55025711-25777501-990D-4A66-8D94-CCFDAC4C8B43
P2860
Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Spores of Clostridium engineer ...... ion and cure of tumors in vivo
@ast
Spores of Clostridium engineer ...... ion and cure of tumors in vivo
@en
type
label
Spores of Clostridium engineer ...... ion and cure of tumors in vivo
@ast
Spores of Clostridium engineer ...... ion and cure of tumors in vivo
@en
prefLabel
Spores of Clostridium engineer ...... ion and cure of tumors in vivo
@ast
Spores of Clostridium engineer ...... ion and cure of tumors in vivo
@en
P2093
P2860
P356
P1433
P1476
Spores of Clostridium engineer ...... ion and cure of tumors in vivo
@en
P2093
Aleksandra M Kubiak
John T Heap
Kim Paesmans
Lieve Van Mellaert
Ludwig Dubois
Phillipe Lambin
Richard Knox
Sarah A Kuehne
P2860
P304
P356
10.18632/ONCOTARGET.1761
P407
P577
2014-04-01T00:00:00Z